Correlation Between MeVis Medical and ARROWHEAD RESEARCH

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MeVis Medical and ARROWHEAD RESEARCH at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MeVis Medical and ARROWHEAD RESEARCH into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MeVis Medical Solutions and ARROWHEAD RESEARCH, you can compare the effects of market volatilities on MeVis Medical and ARROWHEAD RESEARCH and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MeVis Medical with a short position of ARROWHEAD RESEARCH. Check out your portfolio center. Please also check ongoing floating volatility patterns of MeVis Medical and ARROWHEAD RESEARCH.

Diversification Opportunities for MeVis Medical and ARROWHEAD RESEARCH

0.42
  Correlation Coefficient

Very weak diversification

The 3 months correlation between MeVis and ARROWHEAD is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding MeVis Medical Solutions and ARROWHEAD RESEARCH in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ARROWHEAD RESEARCH and MeVis Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MeVis Medical Solutions are associated (or correlated) with ARROWHEAD RESEARCH. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ARROWHEAD RESEARCH has no effect on the direction of MeVis Medical i.e., MeVis Medical and ARROWHEAD RESEARCH go up and down completely randomly.

Pair Corralation between MeVis Medical and ARROWHEAD RESEARCH

Assuming the 90 days trading horizon MeVis Medical Solutions is expected to under-perform the ARROWHEAD RESEARCH. But the stock apears to be less risky and, when comparing its historical volatility, MeVis Medical Solutions is 3.09 times less risky than ARROWHEAD RESEARCH. The stock trades about -0.01 of its potential returns per unit of risk. The ARROWHEAD RESEARCH is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  2,549  in ARROWHEAD RESEARCH on September 14, 2024 and sell it today you would lose (407.00) from holding ARROWHEAD RESEARCH or give up 15.97% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy99.64%
ValuesDaily Returns

MeVis Medical Solutions  vs.  ARROWHEAD RESEARCH

 Performance 
       Timeline  
MeVis Medical Solutions 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in MeVis Medical Solutions are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, MeVis Medical is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
ARROWHEAD RESEARCH 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in ARROWHEAD RESEARCH are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, ARROWHEAD RESEARCH exhibited solid returns over the last few months and may actually be approaching a breakup point.

MeVis Medical and ARROWHEAD RESEARCH Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MeVis Medical and ARROWHEAD RESEARCH

The main advantage of trading using opposite MeVis Medical and ARROWHEAD RESEARCH positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MeVis Medical position performs unexpectedly, ARROWHEAD RESEARCH can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ARROWHEAD RESEARCH will offset losses from the drop in ARROWHEAD RESEARCH's long position.
The idea behind MeVis Medical Solutions and ARROWHEAD RESEARCH pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years